VANCOUVER, July 20 /CNW/ - Response Biomedical Corporation (TSX-V: RBM, OTCBB: RPBIF) announced today it has shipped 100 RAMP Readers to Shionogi & Co., Ltd. for commercial sale in Japan, with the balance of the order to be shipped this summer. As part of this initial purchase order Response Biomedical has also shipped a quantity of BNP tests to be used on these systems. BNP (B-type natriuretic peptide) is a proprietary cardiac marker test to assist in the diagnosis and management of congestive heart failure.
